SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-030218
Filing Date
2023-11-03
Accepted
2023-11-03 16:05:54
Documents
14
Period of Report
2023-11-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20231103_8k.htm   iXBRL 8-K 28667
2 EXHIBIT 3.1 ex_590791.htm EX-3.1 5355
  Complete submission text file 0001437749-23-030218.txt   174768

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arav-20231102.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20231102_def.xml EX-101.DEF 12187
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20231102_lab.xml EX-101.LAB 16396
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20231102_pre.xml EX-101.PRE 12457
8 EXTRACTED XBRL INSTANCE DOCUMENT arav20231103_8k_htm.xml XML 2747
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 231376329
SIC: 2834 Pharmaceutical Preparations